510(k) device
Access NT-proBNP
Beckman Coulter, Inc. · Test, Natriuretic Peptide (NBC, Class II) · First FDA decision Apr 12, 2024, newest Sep 21, 2026Heart attack and heart failure blood testsHeart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
3
Naming "Access NT-proBNP"
MAUDE reports
0
Brand "Access NT-proBNP", since 2015
PubMed studies
4
Mentioning "Access NT-proBNP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Access NT-proBNP
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Access NT-proBNP510(k)
K262109 · Decided Sep 21, 2026 · 90 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL33573Wellpoint FederalUpdated Jul 14, 2026
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL35526Noridian Healthcare Solutions, LLCUpdated Feb 23, 2026
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL34410Palmetto GBAUpdated Dec 22, 2025
- B-type Natriuretic Peptide (BNP) TestingLocal determinationIn effectL33943CGS Administrators, LLCUpdated Nov 26, 2025
- B-type Natriuretic Peptide (BNP) TestingProposed local determinationProposedDL34410Palmetto GBAUpdated Jan 31, 2025
- B-Type Natriuretic Peptide (BNP)Local determinationIn effectL33267First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Access NT-proBNP", any status and sponsor, newest update first.
- PRIMARY-HF: Heart Failure Screening in Primary Care Using Point-of- CarePivotal-lookingRecruiting
Universidade do PortoAcademic, hospital or other
NCT07711821 · 160 participants (planned) · Start Mar 23, 2026 · Primary completion Jul 2027
Device: Cardiac Point-of-Care Ultrasound (POCUS) · For: Heart Failure
Sites: Amadora, Portugal; Lisbon, Portugal; Porto, Portugal · 4 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Access NT-proBNP", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NBC
183 reports: 178 malfunction, 5 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Access NT-proBNP"[tiab]. The summary above synthesizes these.
- A novel NT-proBNP assay for heart failure diagnosis: A prospective, multicenter clinical trial.
Guidi JL, Allen BR, Headden G, et al. · Clin Chim Acta · 2025Multicenter Study, Clinical Trial
- Analytical Characterization and Validation of a Novel Automated Amino-Terminal proB-Type Natriuretic Peptide Assay.
Christenson RH, Alahapperuma D, Allen BR, et al. · J Appl Lab Med · 2025Validation Study
- Evaluation of a New Antibody-Based NT-proBNP Assay for Acute Dyspnea in the Emergency Department.
Allen BR, Guidi JL, Headden G, et al. · Clin Chem · 2026
- Analytical and Clinical Performance Evaluation of a Novel NT-proBNP Assay with De Novo Antibodies across Different Population Groups.
Dupuy AM, Mondesert E, Margueritte L, et al. · J Appl Lab Med · 2026Comparative Study, Evaluation Study
Other devices of this type
Also filed under product code NBC.
- Elecsys proBNP II, Elecsys proBNP II STATRoche Diagnostics · 510(k) 2023
- Triage Bnp Test for Beckman Coulter Immunoassay Systems, Model 98200Biosite Incorporated · 510(k) 2006
- Elecsys Probnp ImmunoassayRoche Diagnostics Corp. · 510(k) 2005
- Triage B-Type Natriuretic Peptide (Bnp) TestBiosite Incorporated · De Novo 2002
- Access BNP IIBeckman Coulter, Inc. · 510(k) 2026
- Alere NT-proBNP for Alinity iAxis-Shield Diagnostics, Ltd. · 510(k) 2026
- VITROS Immunodiagnostic Products NT-proBNP II Reagent PackOrtho Clinical Diagnostics · 510(k) 2021
- Stratus Cs Acute Care Nt-Probnp Testpak, Model CpbnpmDade Behring, Inc. · 510(k) 2007
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.